Georgia USA: Peezy Midstream to reduce public health lab workload

Forte Medical’s US partner Owen Mumford Inc in Georgia USA, is working with the Governor’s Office, GEMA, Homeland Security and the Department of Public Health to provide critical medical devices to hospitals, clinics and healthcare professionals who are facing resource and supply shortages. 

Five hundred thousand Unistik® safety lancets and 5,000 Peezy® urine specimen collection kits will be donated through GEMA to be distributed to Georgia’s healthcare partners and facilities in need. This donation assists those with supply concerns and also relieves the burden on the laboratories by providing a urine specimen collection system that is designed to greatly reduce contaminated samples and lessens the need for repeat testing.

Download the full press release here.

Improving health for women urine collection

Peezy Midstream White Paper: evidence review

We are pleased to deliver our first Peezy Midstream White Paper, summarising the most important clinical evidence to date, showing reduced urine specimen contamination and false-positives using Peezy Midstream. Made in the UK, this world-first tool for routine diagnostic improvement is undergoing NICE Guidance Review.

Improving health for women urine collection

Peezy Midstream in pictures: fewer retests, GP visits, antibiotics. Hand hygiene implicit.

Our new Infographic explains how no-spill, hygienic Peezy Midstream supports routine and prenatal female health by capturing the mid-flow sample for right-first-time treatment.

Peezy is a world-first system, that improves infection control, reduces false-positive dipped samples by up to 70% – and contamination from a national average 22.5% to as low as 0%.

Peezy Midstream also delivers dignity, dry hands, dry bottle, dry floor – and right-first-time treatment, which means labs won’t be overloaded with unnecessary samples for analysis.

Improving UTI diagnosis with Peezy Midstream

Revalidation of urine sample collection methods, quality, contamination

A new study by Dr Linda Collins, Associate Professor, School of Nursing, Kingston and St George’s revalidates assumptions about urinary sample collection methods, quality and contamination. The manuscript is published in the International Urogynecology Journal.

Dr Collins observes: “If midstream is believed to be important the [Peezy] MSU collection device is advantageous.” The study explores the value of bladder sediment and epithelial cells from first-void urine to devise methods of diagnosing and treating Urinary Tract Infection (UTI) more effectively.

Ms Collins’ research is based on detailed and long-term work carried out by Professor James Malone-Lee (Iris Profile). Studies continue.

Forte joins AMR Insights Ambassadors working to reduce global antibiotic immunity

Forte Medical CEO Giovanna Forte has joined the ranks of AMR Insights Ambassadors, a body of life sciences opinion formers and leaders committed to eliminating Antimicrobial resistance. AMR Insights does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms. Forte Medical’s work to reduce unnecessary prescribing through accurate urine specimen collection can contribute to the prevention of AMR growth. Read more about this influential campaigning organisation here.

Peezy Midstream packaging

Medical Device Network: why does urine quality matter?

Urinary tract infections affect an estimated four million women in the UK every year, but in clinical settings they can often go undiagnosed or mistreated due to the inadequate state of urine sampling.

Peezy Midstream is designed to improve the quality of urine samples – but how does it work and why does it matter? Read the full article here.

Live UTI free

LiveUTIFree: our patient partner in the USA and beyond

When it comes to influential patient support and information around urinary tract infection, there are fewer more pertinent partners for Peezy Midstream than LiveUTIFree.

We are thrilled to be working with a partner that works only with the most apposite research and educational institutions where evidence and patient care is paramount to work that benefits women suffering from persistent and chronic UTI.

Peezy Midstream Forte Medical

Peezy Midstream takes centre stage on Hollywood’s biggest night.

Designed by a retired NHS GP, Peezy Midstream, a pioneering British innovation for accurate urine collection to improve early accurate diagnosis of urinary tract infection (UTI) will be included in “Everyone Wins’ goodie bags in Hollywood on 9th February.” Read the full press release here.

Wales Primary Care: Peezy Midstream adoption

Better outcomes for patients in the quickest and safest manner” is the overarching conclusion of a Public Health Wales Clinical Study on Peezy Midstream in primary care.

The study, published here for the first time, reveals that GPs can reap significant savings in cost, time and unnecessary microbiology investigations when using Peezy Midstream for patients presenting with symptoms of Urinary Tract Infection (UTI).

The Study, run under the auspices of the Cardiff and Wales University Health Board shows that the introduction of a simple triage process can identify UTI more efficiently, whilst delivering targeted and less unnecessary antibiotic prescribing, helping the fight against AMR and antibiotic immunity.

“Using the Peezy device in clinical practice has allowed us to completely transform how we approach caring for patients presenting with UTI symptoms. Care is now streamlined, avoiding the need for repeat samples and avoiding mixed growth culture results; meaning antibiotic prescriptions are far more appropriate,” reports Heather Crowley, project lead.

“From a clinical perspective we have seen the number of prescriptions for antibiotics reduce as well as the number of mixed growth culture results; we are able to get the best outcomes for our patients in the quickest and safest manner.”

GP Cluster meetings will roll out in January, to stimulate Peezy Midstream adoption across Wales’ Primary Care services.

Download the full report here.

Diagnostics prevention detection and treatment

Diagnostics: prevention, detection and treatment for the NHS Long Term Plan

The ABHI (Association of British HealthTech Industries) has released its Dx paper showing HealthTech’s role in delivering the NHS Long Term Plan.

Case Study 8 features Peezy Midstream and how it is tackling the annual £122m currently wasted on unreliable urine testing across the UK NHS.

Download the ABHI Dx Diagnostics Long Term Plan document here.